Reply
Hepatology
.
2019 Jul;70(1):440-441.
doi: 10.1002/hep.30632.
Authors
Wei-Yu Kao
1
2
3
4
5
,
Elise Chia-Hui Tan
6
,
Chien-Wei Su
4
5
Affiliations
1
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Taipei Medical University Hospital, Taipei, Taiwan.
2
Department of Internal Medicine, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
3
Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
4
Division of Gastroenterology and Hepatology, Department of Medicine, Taipei Veterans General Hospital, Taipei, Taiwan.
5
Faculty of Medicine, School of Medicine, National Yang-Ming University, Taipei, Taiwan.
6
National Research Institute of Chinese Medicine, Ministry of Health and Welfare, Taipei, Taiwan.
PMID:
30927281
DOI:
10.1002/hep.30632
No abstract available
Publication types
Letter
Comment
MeSH terms
Carcinoma, Hepatocellular*
Hepatitis B, Chronic*
Humans
Liver Neoplasms*
Proton Pump Inhibitors
Substances
Proton Pump Inhibitors